263.51
price down icon5.59%   -15.59
after-market 시간 외 거래: 263.51
loading
전일 마감가:
$279.10
열려 있는:
$279.1
하루 거래량:
1.49M
Relative Volume:
1.98
시가총액:
$18.93B
수익:
$2.90B
순이익/손실:
$467.20M
주가수익비율:
41.37
EPS:
6.37
순현금흐름:
$306.90M
1주 성능:
+24.95%
1개월 성능:
+19.22%
6개월 성능:
-23.62%
1년 성능:
-4.92%
1일 변동 폭
Value
$261.00
$279.63
1주일 범위
Value
$208.71
$291.00
52주 변동 폭
Value
$187.43
$352.33

West Pharmaceutical Services Inc Stock (WST) Company Profile

Name
명칭
West Pharmaceutical Services Inc
Name
전화
(610) 594-2900
Name
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
Name
직원
10,600
Name
트위터
@WestPharma
Name
다음 수익 날짜
2024-10-24
Name
최신 SEC 제출 서류
Name
WST's Discussions on Twitter

WST을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
263.51 20.05B 2.90B 467.20M 306.90M 6.37
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
495.86 175.16B 9.15B 2.61B 1.99B 7.17
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
185.32 52.63B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ALC
Alcon Inc
91.86 45.46B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
RMD
Resmed Inc
275.16 40.10B 5.02B 1.31B 1.56B 8.91

West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-06-24 개시 Barclays Equal Weight
2025-03-18 개시 Evercore ISI Outperform
2025-02-14 업그레이드 Deutsche Bank Hold → Buy
2025-01-08 개시 Citigroup Buy
2024-12-13 개시 Wolfe Research Peer Perform
2024-12-12 업그레이드 UBS Neutral → Buy
2024-02-07 업그레이드 Jefferies Hold → Buy
2023-06-16 업그레이드 BofA Securities Neutral → Buy
2023-04-11 업그레이드 Stephens Equal-Weight → Overweight
2022-12-14 개시 Deutsche Bank Hold
2022-11-30 개시 UBS Neutral
2022-10-28 다운그레이드 BofA Securities Buy → Neutral
2020-11-10 개시 KeyBanc Capital Markets Overweight
2020-10-14 개시 Stephens Equal-Weight
2020-07-21 업그레이드 BofA Securities Neutral → Buy
2020-04-24 업그레이드 BofA/Merrill Underperform → Neutral
2019-12-12 다운그레이드 BofA/Merrill Neutral → Underperform
2019-07-26 업그레이드 BofA/Merrill Underperform → Neutral
2019-05-01 다운그레이드 Jefferies Buy → Hold
2019-04-23 개시 William Blair Outperform
2018-04-25 다운그레이드 BofA/Merrill Neutral → Underperform
2018-01-24 개시 Goldman Neutral
2017-10-17 다운그레이드 BofA/Merrill Buy → Neutral
2017-10-03 개시 Stephens Equal-Weight
2017-09-15 업그레이드 Jefferies Hold → Buy
2016-10-28 업그레이드 Wells Fargo Market Perform → Outperform
2016-09-21 다운그레이드 Wells Fargo Outperform → Market Perform
2016-03-22 개시 Wells Fargo Outperform
2010-05-14 재확인 UBS Neutral
2010-02-23 개시 Jefferies & Co Buy
2008-12-19 개시 UBS Neutral
모두보기

West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스

pulisher
10:16 AM

Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week (July 21-July 25): Are The Others In Your Portfolio? - Benzinga

10:16 AM
pulisher
07:24 AM

Does West Pharmaceutical Services Inc. stock perform well during market downturnsMarket-leading profit generation - jammulinksnews.com

07:24 AM
pulisher
01:52 AM

West Pharmaceutical Services: Low Debt, High Profit, And A Waning Destocking Problem - Seeking Alpha

01:52 AM
pulisher
01:21 AM

KeyBanc maintains Overweight rating on West Pharmaceutical stock - Investing.com

01:21 AM
pulisher
Jul 26, 2025

West Pharmaceutical: Q2 Earnings Snapshot - Erie News Now

Jul 26, 2025
pulisher
Jul 26, 2025

S&P 500 Gains and Losses Today: West Pharmaceutical Services Stock Surges; Dow, LKQ Shares Fall - MSN

Jul 26, 2025
pulisher
Jul 26, 2025

West Pharmaceutical Lifts Full-Year Forecast After Strong Q2 Performance - MSN

Jul 26, 2025
pulisher
Jul 26, 2025

West Pharmaceutical Services Reports Strong Q2 2025 Results - The Globe and Mail

Jul 26, 2025
pulisher
Jul 25, 2025

West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MSN

Jul 25, 2025
pulisher
Jul 25, 2025

De-Risking The Transition From Vial To Drug-Device Combination Product - Med Device Online

Jul 25, 2025
pulisher
Jul 25, 2025

West Pharmaceutical Services, Inc.'s (NYSE:WST) Shares Climb 25% But Its Business Is Yet to Catch Up - simplywall.st

Jul 25, 2025
pulisher
Jul 25, 2025

West Pharmaceutical rises on upbeat results, guidance raise - MSN

Jul 25, 2025
pulisher
Jul 25, 2025

WST Stock Rises on Q2 Earnings Beat, EPS View Up on Tariff & FX Benefit - MSN

Jul 25, 2025
pulisher
Jul 25, 2025

WST: UBS Raises Price Target for West Pharmaceutical Services | WST Stock News - GuruFocus

Jul 25, 2025
pulisher
Jul 25, 2025

West Pharmaceutical Services Reports Strong Q2 Earnings, Surpassing ForecastsNews and Statistics - IndexBox

Jul 25, 2025
pulisher
Jul 25, 2025

Lead Plaintiff Appointed in West Pharmaceutical Class Action - TradingView

Jul 25, 2025
pulisher
Jul 25, 2025

A Quick Look at Today's Ratings for West Pharmaceutical Services(WST.US), With a Forecast Between $325 to $350 - 富途牛牛

Jul 25, 2025
pulisher
Jul 25, 2025

West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2025 Earnings Call Transcript - Insider Monkey

Jul 25, 2025
pulisher
Jul 25, 2025

West Pharmaceutical Services (WST): A High-Margin Growth Story in the Evolving Pharma Packaging Sector - AInvest

Jul 25, 2025
pulisher
Jul 25, 2025

West Pharmaceutical Services (WST) Surpasses Q2 Earnings and Revenue Estimates - Yahoo.co

Jul 25, 2025
pulisher
Jul 25, 2025

Barclays Cautious on West Pharma (WST) on Non-Core Weakness and Injectable Disruption Risks - MSN

Jul 25, 2025
pulisher
Jul 25, 2025

Is West Pharmaceutical Services Inc. a good long term investmentHigh-profit capital plays - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

West Pharmaceutical Services Inc (WST) Q2 2025 Earnings Call Highlights: Strong Growth in ... By GuruFocus - Investing.com Canada

Jul 25, 2025
pulisher
Jul 25, 2025

WST Q2 Deep Dive: High-Value Product Momentum Drives Guidance Increase - TradingView

Jul 25, 2025
pulisher
Jul 24, 2025

West Pharmaceutical Services’ Earnings Call Highlights Strong Growth - TipRanks

Jul 24, 2025
pulisher
Jul 24, 2025

Stock Movers: West Pharma, Chipotle, Southwest - Bloomberg.com

Jul 24, 2025
pulisher
Jul 24, 2025

West Pharmaceutical Services Q2 2025 Earnings Report - MarketBeat

Jul 24, 2025
pulisher
Jul 24, 2025

West Pharma Catapults, Making A Bullish Move, On Unexpectedly Strong Earnings - MSN

Jul 24, 2025
pulisher
Jul 24, 2025

McMahon Takes Over: What’s Next for West Pharmaceutical? - timothysykes.com

Jul 24, 2025
pulisher
Jul 24, 2025

Medical Name Bolts Higher On 'Unexpectedly' Strong Earnings - Investor's Business Daily

Jul 24, 2025
pulisher
Jul 24, 2025

U.S. Indexes Finished Mixed Thursday As West Pharmaceutical Svcs Led, Dow Lagged - Barron's

Jul 24, 2025
pulisher
Jul 24, 2025

West Pharmaceutical Services raises 2025 revenue guidance to $3.04B–$3.06B as HVP components accelerate - MSN

Jul 24, 2025
pulisher
Jul 24, 2025

West Pharma Lifts Forecast As GLP-1 Demand Drives Results - Finimize

Jul 24, 2025
pulisher
Jul 24, 2025

West Pharmaceutical’s New CFO: Market Impact? - timothysykes.com

Jul 24, 2025
pulisher
Jul 24, 2025

Tesla, IBM Slide; West Pharma Soars Among Thursday’s Market Cap Stock Movers - Investing.com Nigeria

Jul 24, 2025
pulisher
Jul 24, 2025

West Pharmaceutical Services Q2 2025: Navigating Contradictions in Growth, Automation, and Revenue Dynamics - AInvest

Jul 24, 2025
pulisher
Jul 24, 2025

West Pharmaceutical Services, Inc. 2025 Q2ResultsEarnings Call Presentation (NYSE:WST) - Seeking Alpha

Jul 24, 2025
pulisher
Jul 24, 2025

West Pharma EPS Jumps 22 Percent in Q2 - The Globe and Mail

Jul 24, 2025
pulisher
Jul 24, 2025

West Pharma EPS Jumps 22 Percent in Q2 - The Motley Fool

Jul 24, 2025
pulisher
Jul 24, 2025

Why Are West Pharmaceutical Services (WST) Shares Soaring Today - Yahoo Finance

Jul 24, 2025
pulisher
Jul 24, 2025

West Pharmaceutical Lifts Forecast As Demand For Drug Components Rises - Finimize

Jul 24, 2025
pulisher
Jul 24, 2025

West Pharmaceutical stock price target raised to $350 from $275 at Evercore ISI - Investing.com UK

Jul 24, 2025
pulisher
Jul 24, 2025

West Pharmaceutical Services: Leveraging HVP Growth and Regulatory Tailwinds for Long-Term Value Creation - AInvest

Jul 24, 2025
pulisher
Jul 24, 2025

West Pharmaceutical Appoints New CFO, Boosting Leadership - StocksToTrade

Jul 24, 2025
pulisher
Jul 24, 2025

Strong Growth Prospects and Margin Recovery Justify Buy Rating for West Pharmaceutical Services - TipRanks

Jul 24, 2025
pulisher
Jul 24, 2025

West Pharmaceutical rockets on surging GLP-1 demand - Sherwood News

Jul 24, 2025
pulisher
Jul 24, 2025

West Pharmaceutical Services Welcomes New CFO, Robert McMahon - timothysykes.com

Jul 24, 2025
pulisher
Jul 24, 2025

West Pharma raises annual profit forecast on strong demand for its drug components - whbl.com

Jul 24, 2025
pulisher
Jul 24, 2025

West Pharma's Strategic Position in the GLP-1 Boom: A High-Margin Growth Play in a $30 Billion Market - AInvest

Jul 24, 2025
pulisher
Jul 24, 2025

West Pharma's Resilient Earnings and Strategic Position in the GLP-1 Boom: A Long-Term Play in the Injectable Drug Supply Chain - AInvest

Jul 24, 2025
pulisher
Jul 24, 2025

West Pharma Lifts Outlook On Surging GLP-1 Demand, Stock Soars - Yahoo Finance

Jul 24, 2025

West Pharmaceutical Services Inc (WST) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

West Pharmaceutical Services Inc 주식 (WST) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Reiss-Clark Cindy
Chief Commercial Officer
Feb 18 '25
Option Exercise
211.00
246
51,940
5,131
MacKay Kimberly Banks
SVP, GC & Corporate Secretary
Feb 18 '25
Option Exercise
211.00
246
51,940
1,605
Favorite Annette F
Sr. VP & Chief HR Officer
Feb 18 '25
Option Exercise
211.00
246
51,940
6,823
Winters Chad
VP, Chief Accounting Officer
Feb 18 '25
Option Exercise
211.00
82
17,313
1,391
Witherspoon Charles
VP & Treasurer
Feb 18 '25
Option Exercise
211.00
66
13,864
1,319
Green Eric Mark
President, CEO and Board Chair
Feb 18 '25
Option Exercise
211.00
2,461
519,269
170,369
Witherspoon Charles
VP & Treasurer
Oct 29 '24
Option Exercise
173.22
478
82,799
1,956
Witherspoon Charles
VP & Treasurer
Oct 29 '24
Sale
310.40
703
218,211
1,253
Abraham Silji
SVP, Chief Technology Officer
Oct 29 '24
Option Exercise
0.00
458
0
3,318
Witherspoon Charles
VP & Treasurer
Aug 19 '24
Option Exercise
102.51
529
54,228
2,507
medical_instruments_supplies BAX
$29.22
price up icon 1.56%
$205.56
price up icon 1.67%
medical_instruments_supplies COO
$74.59
price up icon 1.07%
$66.50
price up icon 0.61%
$74.75
price up icon 1.11%
자본화:     |  볼륨(24시간):